Blood Bank Guy Essentials Podcast 064CE: Granulocyte Transfusion with Ron Strauss
15 snips
Feb 27, 2019 Join Dr. Ron Strauss, a seasoned pediatrician and expert in hematology oncology, as he dives into the sometimes overlooked world of granulocyte transfusions. He discusses the evolving landscape of this practice, citing modern trials that suggest high-dose granulocyte concentrates could yield better outcomes. Dr. Strauss sheds light on the challenges surrounding donor safety and compatibility, while addressing fears about GCSF usage. With a historical perspective and promising future insights, he emphasizes the critical role granulocyte transfusions play in treating infections in leukemia patients.
AI Snips
Chapters
Transcript
Episode notes
Only Offer High-Quality, High-Dose Units
- If you plan to offer granulocytes, ensure your program can reliably produce high-dose units and commit to daily dosing when clinically indicated.
- Avoid half-measures because inconsistent dosing and easy access outside trials undermines both research and patient selection.
Use Experienced Apheresis Donors
- Recruit experienced apheresis donors (regular platelet donors) and fully inform them about GCSF and dexamethasone effects.
- Arrange practical logistics for the GCSF injection about 12 hours before collection so donors can comply safely.
Stimulate And Time Collections Precisely
- Stimulate donors with GCSF plus a corticosteroid to maximize yields, aiming for ~6x10^10 granulocytes per collection.
- Time leukapheresis about 8–16 hours after GCSF to hit the neutrophil peak and collect consistently high doses.